Compare DGII & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DGII | HAE |
|---|---|---|
| Founded | 1985 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.8B |
| IPO Year | 1995 | 1996 |
| Metric | DGII | HAE |
|---|---|---|
| Price | $65.70 | $71.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $48.80 | ★ $84.13 |
| AVG Volume (30 Days) | 339.9K | ★ 918.3K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.05 | N/A |
| EPS | 0.60 | ★ 2.05 |
| Revenue | $430,221,000.00 | ★ $910,373,000.00 |
| Revenue This Year | $18.71 | N/A |
| Revenue Next Year | $7.22 | $5.23 |
| P/E Ratio | $115.42 | ★ $34.07 |
| Revenue Growth | ★ 1.46 | N/A |
| 52 Week Low | $30.69 | $47.32 |
| 52 Week High | $70.79 | $87.32 |
| Indicator | DGII | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 55.00 | 72.12 |
| Support Level | $60.44 | $48.98 |
| Resistance Level | $69.81 | $86.72 |
| Average True Range (ATR) | 2.54 | 2.53 |
| MACD | -0.16 | 0.87 |
| Stochastic Oscillator | 52.85 | 94.85 |
Digi International Inc is a Minnesota corporation that provides business and mission-critical Internet of Things (IoT) connectivity products and services. It operates through two segments: IoT Products & Services, which supports OEMs, enterprise, and government customers in deploying secure IoT connectivity solutions, and IoT Solutions, consisting of SmartSense and its Managed Network-as-a-Service (MNaaS) business offering wireless temperature and condition-based monitoring, employee task management, label printing, and other services. The company generates the majority of its revenue from the IoT Products & Services segment and mainly from the United States, with a presence in Europe, the Middle East and Africa, and the Rest of the world.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.